Skip to main content
OpenTrials
Completed

NCT Number: NCT02284750

Two-stent vs Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions

The purpose of this study is to establish the optimal strategy for stenting in coronary bifurcation lesion.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nanjing First Hospital

Nanjing, Jiangsu, 210006, China

About this study

The current study is designed as a multicenter, randomized and prospective study aiming to compare the effect of two-stenting and simple stenting techniques in patients with complex bifurcation lesions. Based on the previous studies, the rate of 1-year target lesion failure events was around 14% after PCI with provisional stenting. And our previous data showed that this event at 12-month after two-stenting procedure was 7%. Considering the lost to follow-up, it is anticipated that up to 660 patients will be enrolled in the trial. All patients will have repeat angiography at 13 months, with clinical follow-up to 5 years.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of informed consent prior to any study specific procedures;
  • Men and women 18 years and older;.
  • Established indication to PCI according to the guidelines of American Heart Association and American College of Cardiology;
  • Native coronary lesion suitable for drug-eluting stent placement;
  • True bifurcation lesions (Medina 0,1,1/1,1,1);
  • Reference vessel diameter in side branch ≥2.5mm by visual estimation;
  • Complex bifurcation lesions based on DEFINITION study.

Exclusion criteria

  • Pregnancy and breast feeding mother;
  • Co-morbidity with an estimated life expectancy of < 50 % at 12 months;
  • Scheduled major surgery in the next 12 months;
  • Inability to follow the protocol and comply with follow-up requirements or any other reason that the investigator feels would place the patient at increased risk;
  • Unable to provide written informed consent, or fail to follow the protocol;
  • Previous enrolment in coronary intervention device investigation during the study period;
  • Patient with STEMI within 24-hour from the onset of chest pain to admission;
  • Restenosis bifurcation lesions.

Treatment and study plan

Percutaneous coronary intervention

Procedure

Other names: PCI

Primary outcomes

  1. Target lesion failure

    Time frame: 12 months

    Combined end point of: cardiac death, target-vessel myocardial infarction (MI), or target lesion revascularization (TLR).

Secondary outcomes

  1. Cardiac death

    Time frame: 12 months

  2. Target-vessel myocardial infarction

    Time frame: 12 months

  3. Target lesion revascularisation

    Time frame: 12 months

  4. Target vessel revascularisation

    Time frame: 12 months

  5. Stent thrombosis

    Time frame: 12 months

Other outcomes

  1. Acute gain

    Time frame: Intraoperative

    The acute gain was defined as the difference between post- and preprocedural minimal lumen diameter (MLD)

  2. In-stent restenosis

    Time frame: 13 months

    In-stent restenosis was defined as ≥50% diameter stenosis at the follow-up angiogram.

  3. Late lumen loss

    Time frame: 13 months

    The late lumen loss was defined as the difference between post- and follow-up minimal lumen diameter (MLD)

Sponsors and collaborators

Lead sponsor

Nanjing First Hospital, Nanjing Medical University

Other

Registry information

Official study title

A Prospective, Multi-center, Randomized Trial Comparing Two-stent With Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions

Acronym: DEFINITION-II

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Nov 6, 2014
Registry last updated
Dec 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.